P K Locker Selected Research

Therapeutics

1/2001	Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.
9/2000	Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P K Locker Research Topics

Disease

3	Fever (Fevers) 11/2001 - 09/2000
3	Neutropenia 11/2001 - 09/2000
3	Diarrhea 11/2001 - 09/2000
2	Vomiting 11/2001 - 01/2001
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2001 - 02/2001
2	Mucositis 01/2001 - 09/2000
2	Colorectal Neoplasms (Colorectal Cancer) 01/2001 - 09/2000
1	Nausea 11/2001
1	Neoplasms (Cancer) 01/2001

Drug/Important Bio-Agent (IBA)

5	Irinotecan (Camptosar)FDA LinkGeneric 11/2001 - 09/2000
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2001 - 02/2001
2	Carboplatin (JM8)FDA LinkGeneric 05/2001 - 02/2001
2	Fluorouracil (Carac)FDA LinkGeneric 01/2001 - 09/2000
2	Leucovorin (Folinic Acid)FDA Link 01/2001 - 09/2000
1	Topoisomerase I InhibitorsIBA 01/2001
1	thiamine triphosphorate (TTP)IBA 01/2001

Therapy/Procedure

2	Therapeutics 01/2001 - 09/2000